Theriva Biologics shares are trading lower after the company announced a 1-for-25 reverse stock split.
Portfolio Pulse from Benzinga Newsdesk
Theriva Biologics shares declined following the announcement of a 1-for-25 reverse stock split.
August 19, 2024 | 1:21 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Theriva Biologics announced a 1-for-25 reverse stock split, leading to a decline in its share price.
Reverse stock splits often lead to a negative perception among investors as they can be seen as a move to artificially inflate the stock price. This announcement has led to a decline in Theriva Biologics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100